US Stock MarketDetailed Quotes

Champions Oncology (CSBR)

Watchlist

6.035
-0.065-1.07%

Close Apr 17 16:00 ET

6.035
0.0000.00%

Post 20:01 ET

83.81MMarket Cap-35.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Champions Oncology (CSBR) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jan 31, 2026

(Q2)Oct 31, 2025

(Q1)Jul 31, 2025

(FY)Apr 30, 2025

(Q4)Apr 30, 2025

(Q3)Jan 31, 2025

(Q2)Oct 31, 2024

(Q1)Jul 31, 2024

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-373.27%-1.34M

-513.07%-1.74M

92.93%600K

220.35%7.39M

478.19%6.87M

153.32%490K

-148.05%-283K

107.79%311K

-254.51%-6.14M

-162.43%-1.82M

Net income from continuing operations

-106.18%-278K

-67.58%236K

-135.49%-466K

164.61%4.7M

-1,583.49%-1.84M

277.67%4.5M

135.15%728K

151.17%1.31M

-36.38%-7.28M

95.74%-109K

Operating gains losses

--90K

--0

--20K

-32.64%293K

----

--435K

--354K

Depreciation and amortization

-14.32%341K

-10.53%357K

-20.27%358K

-12.16%1.64M

-13.79%394K

-17.26%398K

-17.56%399K

0.90%449K

-16.87%1.87M

-21.61%457K

Deferred tax

----

---181K

----

--0

----

Other non cash items

7.72%321K

41.16%415K

7.27%310K

9.94%1.17M

2.46%291K

6.43%298K

26.72%294K

7.04%289K

11.97%1.07M

110.37%284K

Change In working capital

55.14%-2.21M

-99.80%-3.01M

110.33%199K

83.76%-621K

339.45%7.73M

-1,411.20%-4.92M

-185.75%-1.5M

29.28%-1.93M

-190.10%-3.82M

-13,545.83%-3.23M

-Change in receivables

90.55%-498K

-69.08%-2.08M

211.33%1.76M

27.88%-1.44M

350.84%4.5M

-2,008.80%-5.27M

-206.68%-1.23M

151.41%565K

-252.22%-1.99M

-2,500.00%-1.79M

-Change in prepaid assets

95.24%287K

-115.74%-62K

-36.10%154K

186.23%144K

3.33%-638K

367.27%147K

21.23%394K

8.07%241K

9.24%-167K

0.90%-660K

-Change in payables and accrued expense

561.54%720K

793.47%1.7M

45.22%-344K

-480.34%-1.35M

-141.99%-325K

-124.88%-156K

81.02%-245K

-355.28%-628K

-84.66%356K

-39.20%774K

-Change in other current assets

----

--0

---169K

--1K

-Change in other current liabilities

-10.95%-375K

-42.47%-473K

-10.22%-356K

-13.26%-1.32M

-6.09%-331K

-9.74%-338K

-29.18%-332K

-10.62%-323K

-28.89%-1.17M

-136.36%-312K

-Change in other working capital

-433.33%-2.34M

-2,172.83%-2.09M

43.10%-1.01M

590.34%3.35M

465.78%4.52M

93.92%702K

-105.04%-92K

-9.06%-1.78M

-140.04%-683K

-223.56%-1.24M

Cash from discontinued investing activities

Operating cash flow

-373.27%-1.34M

-513.07%-1.74M

92.93%600K

220.35%7.39M

478.19%6.87M

153.32%490K

-148.05%-283K

107.79%311K

-254.51%-6.14M

-162.43%-1.82M

Investing cash flow

Cash flow from continuing investing activities

66.67%-14K

-157.45%-242K

-46K

53.47%-389K

-8,533.33%-253K

54.35%-42K

-18.99%-94K

70.89%-836K

100.39%3K

Net PPE purchase and sale

66.67%-14K

-157.45%-242K

---46K

53.47%-389K

-8,533.33%-253K

54.35%-42K

-18.99%-94K

--0

70.89%-836K

100.39%3K

Cash from discontinued investing activities

Investing cash flow

66.67%-14K

-157.45%-242K

---46K

53.47%-389K

-8,533.33%-253K

54.35%-42K

-18.99%-94K

--0

70.89%-836K

100.39%3K

Financing cash flow

Cash flow from continuing financing activities

-36K

-29.71%168K

62.16%-14K

132.26%170K

13.51%-32K

78.36%239K

93.73%-37K

-4,890.91%-527K

50.67%-37K

Net issuance payments of debt

-2.63%-39K

-5.41%-39K

-2.70%-38K

-2.74%-150K

0.00%-38K

-11.76%-38K

50.00%-37K

---37K

---146K

---38K

Net common stock issuance

----

--0

-756.76%-634K

--0

Proceeds from stock option exercised by employees

-92.11%3K

-25.00%207K

--24K

26.48%320K

500.00%6K

--38K

15.00%276K

--0

197.65%253K

200.00%1K

Cash from discontinued financing activities

Financing cash flow

---36K

-29.71%168K

62.16%-14K

132.26%170K

13.51%-32K

--0

78.36%239K

93.73%-37K

-4,890.91%-527K

50.67%-37K

Net cash flow

Beginning cash position

209.22%8.52M

257.02%10.33M

273.76%9.79M

-74.13%2.62M

-28.33%3.2M

-50.05%2.75M

-40.60%2.89M

-74.13%2.62M

12.33%10.12M

-61.63%4.47M

Current changes in cash

-410.04%-1.39M

-1,210.87%-1.81M

97.08%540K

195.56%7.17M

455.84%6.58M

142.87%448K

-121.43%-138K

105.22%274K

-775.07%-7.5M

-21.15%-1.85M

End cash Position

122.58%7.13M

209.22%8.52M

257.02%10.33M

273.76%9.79M

-28.33%3.2M

-50.05%2.75M

-40.60%2.89M

-74.13%2.62M

Free cash flow

-407.14%-1.38M

-424.40%-1.98M

78.14%554K

200.34%7M

464.86%6.62M

144.31%448K

-173.92%-377K

106.68%311K

-733.91%-6.97M

-24.86%-1.81M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Jan 31, 2026	(Q2)Oct 31, 2025	(Q1)Jul 31, 2025	(FY)Apr 30, 2025	(Q4)Apr 30, 2025	(Q3)Jan 31, 2025	(Q2)Oct 31, 2024	(Q1)Jul 31, 2024	(FY)Apr 30, 2024	(Q4)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-373.27%-1.34M	-513.07%-1.74M	92.93%600K	220.35%7.39M	478.19%6.87M	153.32%490K	-148.05%-283K	107.79%311K	-254.51%-6.14M	-162.43%-1.82M
Net income from continuing operations	-106.18%-278K	-67.58%236K	-135.49%-466K	164.61%4.7M	-1,583.49%-1.84M	277.67%4.5M	135.15%728K	151.17%1.31M	-36.38%-7.28M	95.74%-109K
Operating gains losses	--90K	--0	--20K	-32.64%293K	----	----	----	----	--435K	--354K
Depreciation and amortization	-14.32%341K	-10.53%357K	-20.27%358K	-12.16%1.64M	-13.79%394K	-17.26%398K	-17.56%399K	0.90%449K	-16.87%1.87M	-21.61%457K
Deferred tax	----	----	----	---181K	----	----	----	----	--0	----
Other non cash items	7.72%321K	41.16%415K	7.27%310K	9.94%1.17M	2.46%291K	6.43%298K	26.72%294K	7.04%289K	11.97%1.07M	110.37%284K
Change In working capital	55.14%-2.21M	-99.80%-3.01M	110.33%199K	83.76%-621K	339.45%7.73M	-1,411.20%-4.92M	-185.75%-1.5M	29.28%-1.93M	-190.10%-3.82M	-13,545.83%-3.23M
-Change in receivables	90.55%-498K	-69.08%-2.08M	211.33%1.76M	27.88%-1.44M	350.84%4.5M	-2,008.80%-5.27M	-206.68%-1.23M	151.41%565K	-252.22%-1.99M	-2,500.00%-1.79M
-Change in prepaid assets	95.24%287K	-115.74%-62K	-36.10%154K	186.23%144K	3.33%-638K	367.27%147K	21.23%394K	8.07%241K	9.24%-167K	0.90%-660K
-Change in payables and accrued expense	561.54%720K	793.47%1.7M	45.22%-344K	-480.34%-1.35M	-141.99%-325K	-124.88%-156K	81.02%-245K	-355.28%-628K	-84.66%356K	-39.20%774K
-Change in other current assets	----	----	----	--0	--0	--0	--0	--0	---169K	--1K
-Change in other current liabilities	-10.95%-375K	-42.47%-473K	-10.22%-356K	-13.26%-1.32M	-6.09%-331K	-9.74%-338K	-29.18%-332K	-10.62%-323K	-28.89%-1.17M	-136.36%-312K
-Change in other working capital	-433.33%-2.34M	-2,172.83%-2.09M	43.10%-1.01M	590.34%3.35M	465.78%4.52M	93.92%702K	-105.04%-92K	-9.06%-1.78M	-140.04%-683K	-223.56%-1.24M
Cash from discontinued investing activities
Operating cash flow	-373.27%-1.34M	-513.07%-1.74M	92.93%600K	220.35%7.39M	478.19%6.87M	153.32%490K	-148.05%-283K	107.79%311K	-254.51%-6.14M	-162.43%-1.82M
Investing cash flow
Cash flow from continuing investing activities	66.67%-14K	-157.45%-242K	-46K	53.47%-389K	-8,533.33%-253K	54.35%-42K	-18.99%-94K	0	70.89%-836K	100.39%3K
Net PPE purchase and sale	66.67%-14K	-157.45%-242K	---46K	53.47%-389K	-8,533.33%-253K	54.35%-42K	-18.99%-94K	--0	70.89%-836K	100.39%3K
Cash from discontinued investing activities
Investing cash flow	66.67%-14K	-157.45%-242K	---46K	53.47%-389K	-8,533.33%-253K	54.35%-42K	-18.99%-94K	--0	70.89%-836K	100.39%3K
Financing cash flow
Cash flow from continuing financing activities	-36K	-29.71%168K	62.16%-14K	132.26%170K	13.51%-32K	0	78.36%239K	93.73%-37K	-4,890.91%-527K	50.67%-37K
Net issuance payments of debt	-2.63%-39K	-5.41%-39K	-2.70%-38K	-2.74%-150K	0.00%-38K	-11.76%-38K	50.00%-37K	---37K	---146K	---38K
Net common stock issuance	----	----	----	--0	--0	--0	--0	--0	-756.76%-634K	--0
Proceeds from stock option exercised by employees	-92.11%3K	-25.00%207K	--24K	26.48%320K	500.00%6K	--38K	15.00%276K	--0	197.65%253K	200.00%1K
Cash from discontinued financing activities
Financing cash flow	---36K	-29.71%168K	62.16%-14K	132.26%170K	13.51%-32K	--0	78.36%239K	93.73%-37K	-4,890.91%-527K	50.67%-37K
Net cash flow
Beginning cash position	209.22%8.52M	257.02%10.33M	273.76%9.79M	-74.13%2.62M	-28.33%3.2M	-50.05%2.75M	-40.60%2.89M	-74.13%2.62M	12.33%10.12M	-61.63%4.47M
Current changes in cash	-410.04%-1.39M	-1,210.87%-1.81M	97.08%540K	195.56%7.17M	455.84%6.58M	142.87%448K	-121.43%-138K	105.22%274K	-775.07%-7.5M	-21.15%-1.85M
End cash Position	122.58%7.13M	209.22%8.52M	257.02%10.33M	273.76%9.79M	273.76%9.79M	-28.33%3.2M	-50.05%2.75M	-40.60%2.89M	-74.13%2.62M	-74.13%2.62M
Free cash flow	-407.14%-1.38M	-424.40%-1.98M	78.14%554K	200.34%7M	464.86%6.62M	144.31%448K	-173.92%-377K	106.68%311K	-733.91%-6.97M	-24.86%-1.81M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm